Get started

Covid19stock

APT - Swing TradeTook an entry here on swing trade on APT. Entry between $20.00 - $20.50. Stop Loss at: $19.40 (around 4%) -- You can even go tighter on this one if you'd like Profits: $24.00 (around 19% profit) Give us a follow and shoot us a Like for more analysis updates. Cheers! Disclaimer: I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read here. Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on here, expressed or implied herein, are committed at your own risk, financial or otherwise
AMEX:APTLong
by MannyLo
Beat Earnings. Raised Guidance. No Debt. USA Protective GearAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada. Net Sales of $25.5 Million, an Increase of 123.4% Year-over-Year Provides Update on Orders for Personal Protective Equipment (PPE) Net sales for the second quarter of 2020 were $25.5 million, compared to $11.4 million for the second quarter of 2019, up 123.4% year-over-year. Net income for the second quarter of 2020 was $6.2 million, or $0.46 per diluted share, compared to $1.0 million, or $0.08 per diluted share, for the second quarter of 2019, up 475% on a per share basis. NOGALES, Ariz., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period ended June 30, 2020. finance.yahoo.com Need I say anymore? Earnings blew past Wall Street Estimates. APT raised guidance and the company has no debt. Protective gear and N95 masks will be a part of the Worldwide dress code through 2020 and into 2021 even if a vaccine is approved because not everyone will want to take the vaccine shot. Today's sell off was outrageous and an early Christmas gift for anyone looking for a quality company that makes protective gear & N95 masks in the USA! Target: $32 Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
AMEX:APTLong
by HotCharts
2
Rapid Recovery Respiratory Failure - COVID-19 TreatmentRelief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary hypertension; and atexakin alfa that has completed Phase I clinical trial to treat peripheral diabetic neuropathy. Relief Therapeutics Holding AG is based in Geneva, Switzerland. RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells - Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) was seen in patients with severe medical comorbidities after three days of treatment with RLF-100 under FDA Emergency Use IND authorization at multiple clinical sites - Aviptadil is being developed as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes - RLF-100 is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide VIP), which has been granted FDA Fast Track Designation, FDA emergency use IND authorization, and an expanded access protocol finance.yahoo.com I think this stock could spike like Moderna Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
OTC:RLFTFLong
by HotCharts
1
Sanofi, leading in the fight for COVID-19Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/ 2 study to start in September, followed by a Phase 3 study by the end of 2020. If data are positive, regulatory approval could be achieved by the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant to produce up to one billion doses per year overall. Sanofi and GSK are committed to making the vaccine available globally As we are hitting the golden zone in FIB retrace. Im going to put this on watch.
EURONEXT:SAN
by Wteres
Bullish Charts - Plasma Play, FDA Approved Plasma FacilitiesADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey. BREAKING NEWS TODAY - 07/30/2020 ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients. www.benzinga.com On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location. finance.yahoo.com With the FDA asking for everyone to donate plasma, this stock could rip! Plasma stocks ripped today and continue to rip. This company already is up and running one plasma facility. Game On! Long DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:ADMALong
by HotCharts
Bullish Charts - Vaccine Reduced COVID-19 into Common ColdAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois. On 07/15/20, Researchers said AbbVie's Tricor reduced severity of COVID-19 into "NOTHING WORSE THAN A COLD." www.yahoo.com In my opinion, a vaccine doesn't get any better than this. AbbVie has the vaccine! Where is all the great news about Tricor killing COVID-19.??? If the stock can break through around $107, I think it's going to spike hard! The daily chart looks great. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:ABBVLong
by HotCharts
Bullish Charts - COVID-19 VaccineGilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California. On 07/11/20, Gilead announced its drug Remdesivir can reduce risk of death in COVID-19 patients. On 07/10/20, Former FDA Commissioner Scott Gottlieb said Remdesivir data showed improved COVID-19 Recovery & Reduced Risk of Death by 62%. The COVID-19 drug alone could be a huge revenue boom for Gilead into the future as many countries stockpile & use it. On the Daily Chart, it looks to me like a Pennant has formed with a breakout coming, Bullish Volume, Bullish PMO, Bullish MACD, Bullish RSI, Bullish OBV, Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
1
Bullish Industry - Protective Gear, N95 Masks, Robust EarningsAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada. On 06/25/20, Alpha Pro announced it will join the Russell 2000 and Russell 3000 Indexes. The company is also currently included in the Russell Microcap Index. On 06/23/20, Business Wire announced Aplha Pro serves a $15 Billion dollar Worldwide industry. On 05/06/20, Alpha Pro announced ROBUST earnings that blew away Wall Street estimates. Q1 EPS $0.39 up from $0.09 YoY. In addition, Alpha Pro had 16% growth in its Building Supply segment. The company has experienced a SURGE in customer demand for its "Proprietary" N-95 Particulate Respirator face mask and other PPE products as a result of the pandemic. As of May 1, 2020, the company has approx. $46.8 million in orders for the N-95 mask alone. Alpha Pro has also experienced a robust demand for its "Face Shield" products with orders totaling $13.3 Million as of May 1, 2020. Alpha Pro ended the 1st qtr of 2020 with working capital of $31.6 million and a current ration of a solid 4:1 - (Bullish Ratio - Strong Cash Position) The company currently has NO OUTSTANDING DEBT and an unused $3.5 million credit line. With the recent uptick in COVID-19 infections, more and more states are requiring masks for all activities especially for frontline employees. The need for Alpha Pro products is not going away anytime soon. Rapid Growth should continue far into 2021 and beyond. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
AMEX:APTLong
by HotCharts
SPX and the Covid Death NumbersTechnical introduction I don't know who is going to read this so I am going to be a bit more detailed than normal to explain some of this indicators. The moving average convergence/divergence indicator, also known as the 'Mac D" defaul calculations is to that the differnce between the 12 period Exponential Moving Average (EMA) and subtract the 26 period EMA. So if the MACD reads 5 then the 12 EMA is 5 units above the 26. That doens't mean alot of the difference is between 100 and 105 but it does mean a lot if the difference is between a 1 and a 6. Likewise if you have a negative number it means the 12 EMA is below the 12 EMA, a sign price is decreasing The average of the MACD is called the signal line and the default is set to a 9 period look back So when the MACD is above the signal line the change in momentum is positive for nine periods and when it is below 0 the change in momentum is negative, and when the reading is zero the change in momentum is flat. If you minus the MACD from the signal line you get the MACD Histogram. You can use both the MACD proper, the signal line, or the Histogram to look for divergences. Time for the Divergence primer: Normal Divergence (Trend Reversal) Bearish: Higher highs on price action but lower highs on the indicator Bullish: Lower lows on price action but higher lows on the indicator Hidden (Trend Continuation) Bearish: Lower high on the price action and higher highs on the indicator Bullish: Higher low on the price action and a lower low on the indicator COVID Analysis Beginning with the Covid Death Numbers on the right The death count can only go up but the MACD and histogram can give us some idea how the momentum can change. When the 12 and 26 EMAs are furthest apart the MACD has its highest score, which we see happens around May 9th. When the MACD and Signal line cross its a sign that the rate of change has been roughly constant for 12 to 26 periods. As the MACD dips below the signal line it means the rate of reported deaths is decreasing. Deaths are still going up, but the rate is decreasing. At our current date we see the MACD looks very close to crossing the signal line. That means that death rate is going to be increasing. And because there is so much averaging going on between the 12, and 26 EMAs and the signal smoothing for 9 periods we know this change in rate isn't random fluctuation. In other words, a stained MACD Signal Cross predicts or suggest the reported number of COVID deaths is going to pop. Probably in a big way. If we start to see the MACD histogram rounding off positive we can get some sort of idea if there is going to be some divergences and what that means for the death rate. SPX Technical Analysis The divergence primer tells us that a lower high on price action but a higher high on a indicator is Hidden Bearish Divergence. This suggest strongly that the trend is a continuation of a downtrend. Both the MACD and the Histogram are showing this Hidden bearish divergence. The orange chart formation is a rising wedge positioned as a bull trap. The blue line shows where previous support at the years open turned into resistance at the top of my proposed bear trap. The MACD appears to be finding something resembling support on the Signal Line. This means that there has been some considerable sideways action. Sideways action ultimately has to pick a direction and the hidden bearish divergence suggest it will be to the downside. All of this is on a 3d intra week chart. Fundamental Analysis An increase in the rate of COVID death numbers may behoove a government response and/or a change in optimism in traders and investors. We can see the hot spotes a shifting in the US away from the Easter Seaboard down the Gulf of Mexico and elsewhere. Mass human psychology means there were always going to be another wave, if not a third. How to adapt to that broadly isn't the question here, it is what one should do financially. I am not a financial advisor, and i am not your financial advisor even if I was one. I am taking a short position against SPX. www.npr.org
Editors' picks
FOREXCOM:SPX500Short
by This_Guhy
20
End of Covid Virus had begun. Great good times aheadHi all, Today I have come to publish this post as some inner voice forced me to do this. We reached all time high with respect to covid cases. We know covid shook the nations and disturbed our daily lives. Some of us forced into medieval ages through lock downs. Agony and Suffering are most sad things that humans can't escape but through God we can overcome them. COVID times are testing our humanity and nature of our behavior. Are we loving our neighbors or we selfish to self survive? Self Survival doesn't help. The best way to end the covid is to help your neighbors and friends as you want to help your family members. Spread Love and Humanity in these hardest days. Saying that I am predicting that COVID virus has become so week, from today covid cases will drastically fall down. Governments will realize and improve the health care if they don't we shall remind them. Happy Joyful days are coming, Economy will boost from this worst state. Believe in your inner strength and realize that God has given you power, Use your power through prayers. Pray for the end of the COVID and return of normal life for all our human society. God Heal and Bless you all. Best Wishes.
C
by UnknownUnicorn6209745
24
KNOS ascending triangle. Huge Potential with Covid 2nd waveCurrently KNOS is in an ascending bull flag. Why KNOS has huge potential within the months to come: Their air filtration technology fully removes harmful allergens, bacteria, viruses (including the flu) and even gases from your breathing space. This product far outperforms the outdated 1940’s technology of a HEPA filter, and eliminates the shortcomings of any other air Kronos owns 12 patents in total, all focused on air filtration, and the removal of harmful bacteria, allergens and viruses from the breathing space. Patents: US 7,150,780 B2 US 6,937,455 B2 US 6,919,698 B2 US 6,727,657 B2 US 7,122,070 B1 US 6,963,479 B2 US 7,053,565 B2 US 6,664,741 B1 US 2010/0047115 A1 US 2009/0022340 A1 US 2010/0065510 A1 US 2010/0065510 A1 June 18th, 2020, Kronos signs deal to acquire US based leader in electronics manufacturing industry including its 85,000 square foot manufacturing facility. Kronos announced that it has signed a “Letter of Intent” with a privately held company to acquire a manufacturing facility for its consumer electronics products operations. The Company plans to manufacture a variety of electronic products, including medical ventilators and other vitally necessary medical equipment in addition to its flagship air purification products. Having their own manufacturing facility would not only help them to scale production to address growing sales and product line expansion, but also to develop new products and bring those to market much faster under a more efficient and controllable cost structure. June 29th, 2020 Kronos starts taking pre-orders for air purification products.
OTC:KNOSLong
by OttersOnly
3
COVID-19 Vaccine, 1st Effective Drug, USA Secures 500,000 DosesHHS secures 500,000 doses of remdesivir. The Trump administration has secured 500,000 doses of remdesivir, the first drug shown to be effective at treating hospitalized coronavirus patients, ensuring these doses will be for U.S. use. This could mean huge profits for GILD. Indicators are starting to turn up, Bullish. Daily Chart is turning Bullish. I think if the stock breaks above the $77.00 range, it's going to spike. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
4
Grifols: A new bullish channel up to +18%?Focused on hemoderivatives (blood plasma), Grifols is great value by most of investors. Even though the company might be one day spitted by any scandal on how it is gathering the plasma in the US, americans have got a high stake on it and today it is focusing on an hyperimmune immunoglobulin with specific antibodies against the SARS-CoV-2 virus. Grifols estimated an impact on its accounts of €200 million and many rating houses have downgraded the stock. Its 2019's profits were up 4.8% to 625 million and an EBITDA of 1,434 million (+17,3% YoY). In 2020, Q1 Net profits were up 63% and EBITDA 14.9%. Results on its tests will be presented in July (the mandatory 14 days to see whether the virus is gone or not). We may experience volatility in the price of the company until July 01. According to some news, Grifols' margins were not attractive and that is why the correction of the share price has taken place. Technically speaking, the company might be immersed in a bullish channel started on March 16 and closing out a triangle started on Feb 20. We could expect the share price go at least up to 29.40 level in the next days. Best price to enter Grifols might be 27€. Also, note that when markets are down, Grifols is up acting like a safe haven asset.
BME:GRFLong
by alexinve
Bullish Charts - COVID-19 Play, N95 Masks, Robust EarningsAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada. Today looks like a solid break-out in a down market. Alpha Pro is part of a $15 Billion dollar industry. With N95 masks in high demand, I think there's only one way this stock can go, UP... On 5/6/2020, the company reported earnings of $0.39 up from $0.09. Revenue spiked with 47.5% sales growth. On 5/6/2020, The company announced it was debt free. Not many companies can say they're debt free. 52-Week high is around $41.00 Last earnings report was a blockbuster! The company blew past Wall Street estimates and I think they'll continue blowing past estimates into the future. Indicators are Bullish. Daily Chart looks great. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
AMEX:APTLong
by HotCharts
Indra: Seizing sideways momentum call opportunity?Indra is moving inside a lateral channel with a slight bearish trend. In the last days there have been good news about projects that are being signed (i.e. Defense, Ireland) but it looks like global pandemic situation is making investors undecisive whether to hold positions on the stock or withdraw. Lond term trend is clearly bullish. The company was planning to get back to dividend payments suspended back in 2014 and now due to covid19 it has left this topic in standby. The truth is that if I think markets are going to throw-back around July 14, IDR may not have time to do its last swing and may go further down to levels seen in 2012. However, if tomorrow decreases a sharp 6%, depending on the global market news we might experience a rebound on Monday or a continuing decline until 6.395€, the base of the slightly bearish channel. So we must be very focused on what happens tomorrow in macros, news, covid19 new outbreak and market sentiment and operate consequently. On the weekend there might be as well some news or none that may affect the global stockmarket sentiment. One thing is for sure: There is a lot of volatility and one could benefit or lose with it.
BME:IDRLong
by alexinve
1
CHGG - BREAKOUT / NEW HIGHSChegg, Inc. operates direct-to-student learning platform that supports students on their journey from high school to college and into their career with tools designed to help them pass their test, pass their class, and save money on required materials. Strong fundamentals showing increasing earnings for the past quarters above +40%, revenues accelerating +35% consistently for the past quarters, with margins expanding and positive earnings revisions for 2021. One of the stronger stocks on my watchlist of companies whose earnings are growing not despite of the pandemic but because of it. Stock already broke out from a pattern resistance last week with accelerating volume and an entry position for potential range expansion is shown on the chart. Expectation is for price to continue its trend up from an early stage breakout with above average volume and find support on it's 10-day EMA on pullbacks.
NYSE:CHGGLong
by TradingMavericks
FCC Approved Contactless Temperature Scanner - Options ActivityJune 8, 2020 Remark Holdings (MARK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. Remark offers products that will help in the crisis and the company owns a stake in Sharecare, the medical startup co-founded by celebrity doctor Mehmet Oz and backed by Oprah Winfrey and Sony (NYSE:SNE). Remark’s innovative products include thermal imaging and scanning solutions that are already in use in Nevada. This artificial intelligence-driven tech can “scan high traffic areas to detect individuals with higher than acceptable skin temperature,” the Wall Street Journal reports. LAS VEGAS, May 27, 2020 /PRNewswire/ -- Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence ("AI") solutions and digital media properties, today announced the launch of a new website, RemarkThermal.com. "Interest in our thermal imaging and scanning solutions is robust across many industries and we believe that enthusiasm warrants a dedicated site for information about our novel solutions," stated Kai-Shing Tao, Chairman and Chief Executive Officer of Remark Holdings, Inc. "What differentiates Remark's thermal cameras are its capabilities beyond thermal temperature scanning. Our proprietary AI software enables monitoring various tasks including people counting, PPE enforcement such as mask wearing, social distancing compliance, contactless access to doors and gates, attendance management, touchless employee check in, object counts, behavior detection, intelligent surveillance and theft control." Remark's Thermal Imaging is used to scan high traffic areas to detect individuals with higher than acceptable skin temperature and track the subject for secondary screening. Each of the Thermal Imaging products is customizable and can operate as a standalone or integrated into centralized control systems, specific to the needs of the customer. Real-time video and audible alerts from individual systems can be sent to a centralized system or monitored live. Systems can be mounted on walls, tripods, or ceilings to scan wider areas. For additional information, please refer to: www.RemarkThermal.com. Options are active. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
6